PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2007.39.3.99200739399Oxaliplatin, 5-FU, Folinic Acid as First-line Palliative Chemotherapy in Elderly Patients with Metastatic or Recurrent Gastric CancerIn Sil Choi, Do-Youn Oh, Byoung-Su Kim, Keun-Wook Lee, Jee Hyun Kim, Jong-Seok Leehttp://www.e-crt.org/upload/pdf/crt-39-99.pdf, http://www.e-crt.org/upload/pdf/crt-39-99.pdf
BMC Cancer10.1186/1471-2407-14-5212014141Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancerGunnar Folprecht, Susanne Hamann, Katharina Schütte, Tanja Trarbach, Jan Stoehlmacher-Williams, Gerhard Ehningerhttp://link.springer.com/content/pdf/10.1186/1471-2407-14-521.pdf, http://link.springer.com/article/10.1186/1471-2407-14-521/fulltext.html, http://link.springer.com/content/pdf/10.1186/1471-2407-14-521
European Journal of Cancer Supplements10.1016/s1359-6349(05)80894-8200532167598 ORAL Randomised comparison of 5-FU/folinic acid plus irinotecan (FOLFIRI) and irinotecan plus oxaliplatin (IROX) in first-line therapy of metastatic colorectal cancer (CRC): the fire-trialhttps://api.elsevier.com/content/article/PII:S1359634905808948?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634905808948?httpAccept=text/plain
BMC Cancer10.1186/1471-2407-6-125200661Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trialD Santini, F Graziano, V Catalano, M Di Seri, E Testa, AM Baldelli, P Giordani, A La Cesa, B Spalletta, B Vincenzi, A Russo, M Caraglia, V Virzi, S Cascinu, G Toninihttp://link.springer.com/content/pdf/10.1186/1471-2407-6-125.pdf, http://link.springer.com/article/10.1186/1471-2407-6-125/fulltext.html, http://link.springer.com/content/pdf/10.1186/1471-2407-6-125, https://link.springer.com/content/pdf/10.1186/1471-2407-6-125.pdf
European Journal of Cancer Supplements10.1016/s1359-6349(05)80938-3200532181-182642 POSTER Cetuximab plus oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) for the epidermal growth factor receptor (EGFR)-expressing metastatic colorectal cancer (mCRC) in the first-line setting: a phase II studyhttps://api.elsevier.com/content/article/PII:S1359634905809383?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634905809383?httpAccept=text/plain
European Journal of Cancer Supplements10.1016/s1359-6349(05)80897-3200532168601 ORAL Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): results of the safety and efficacy analysishttps://api.elsevier.com/content/article/PII:S1359634905808973?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634905808973?httpAccept=text/plain
Chemotherapy10.1159/0003278402011573230-235Comparison of Cisplatin-5-Fluorouracil-Folinic Acid versus Modified Docetaxel-Cisplatin-5-Fluorouracil Regimens in the First-Line Treatment of Metastatic Gastric CancerF. Tugba Kos, Dogan Uncu, Nuriye Özdemir, Burcin Budakoglu, Hatice Odabaş, Hüseyin Abali, Berna Oksuzoglu, Sercan Aksoy, Nurullah Zenginhttps://www.karger.com/Article/Pdf/327840, http://www.karger.com/Article/Pdf/327840
Cancer Chemotherapy and Pharmacology10.1007/s00280-010-1281-5201067141-48Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trialMatteo Dalla Chiesa, Gianluca Tomasello, Sebastiano Buti, Rodrigo Kraft Rovere, Matteo Brighenti, Silvia Lazzarelli, Gianvito Donati, Rodolfo Passalacquahttp://link.springer.com/content/pdf/10.1007/s00280-010-1281-5.pdf, http://link.springer.com/article/10.1007/s00280-010-1281-5/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00280-010-1281-5
Cancer Research and Treatment10.4143/crt.2011.43.3.1542011433154-159Efficacy and Safety of Oxaliplatin, 5-Fluorouracil, and Folinic Acid Combination Chemotherapy as First-Line Treatment in Metastatic or Recurrent Gastric CancerHan Jo Kim, Jun Young Eun, Young Woo Jeon, Jina Yun, Kyoung Ha Kim, Se Hyung Kim, Hyun Jung Kim, Sang-Cheol Lee, Sang Byung Bae, Chan Kyu Kim, Nam Su Lee, Kyu Taek Lee, Seong-Kyu Park, Jong-Ho Won, Dae Sik Hong, Hee Sook Parkhttp://www.e-crt.org/upload/pdf/crt-43-154.pdf, http://www.e-crt.org/upload/pdf/crt-43-154.pdf
European Journal of Cancer Supplements10.1016/s1359-6349(05)80960-7200532188664 PUBLICATION Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC)https://api.elsevier.com/content/article/PII:S1359634905809607?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634905809607?httpAccept=text/plain